Subclinical cardiac dysfunction and exercise performance in childhood cancer survivors

Pediatric Blood and Cancer

Volumn 56, Issue 1, 2011, Pages 122-126

  De Caro, Enrico ^a   Smeraldi, Attilio ^a   Trocchio, Gianluca ^a   Calevo, MariaGrazia ^a   Hanau, Guia ^a   Pongiglione, Giacomo ^a  

^a G GASLINI INSTITUTE   (Italy)

Author keywords

Anthracyclines; Cardiopulmonary exercise test; Children; Exercise echocardiography

Indexed keywords

ANTHRACYCLINE;

ADOLESCENT; ARTICLE; CANCER SURVIVOR; CARDIOPULMONARY EXERCISE TEST; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASE; HEART FUNCTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE WALL; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RISK FACTOR; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ANTHRACYCLINES; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ECHOCARDIOGRAPHY, STRESS; EXERCISE TEST; FEMALE; HEART DISEASES; HUMANS; INFANT; MALE; NEOPLASMS; OXYGEN CONSUMPTION; SURVIVORS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 78649640869     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22606     Document Type: Article

References (32)

1. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 2006; 355: 1572-1582.
2. Geenen MM, Cardous-Ubbink MC, Kremer LCM, et al. Medical assessment of adverse health outcomes in long-term survivors of childhood cancer. JAMA 2007; 297: 2705-2715.
3. De Wolf D, Suys B, Matthys D, et al. Stress echocardiography in the evaluation of late toxicity after moderate dose of anthracycline therapy in childhood. Int J Pediatr Hematol Oncol 1994; 1: 399-404.
4. De Wolf D, Suys B, Verhaaren H, et al. Low-dose dobutamine stress echocardiography in children and young adults. Am J Cardiol 1998; 81: 895-901.
5. Hamada H, Ohkubo T, Maeda M, et al. Evaluation of cardiac reserved function by high-dose dobutamine-stress echocardiography in asymptomatic anthracycline-treated survivors of childhood cancer. Pediatr Int 2006; 48: 313-320.
6. Paiva MG, Petrilli AS, Moises VA, et al. Cardioprotective effect of dexrazoxane during treatment with doxorubicin: A study using low-dose dobutamine stress echocardiography. Pediatr Blood Cancer 2005; 45: 902-908.
7. Klewer SE, Goldberg SJ, Donnerstein RL, et al. Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer. JACC 1992; 19: 394-401.
8. Cottin Y, L'hullier I, Casasnovas O, et al. Dobutamine stress echocardiography identifies antrhacycline cardiotoxicity. Eur J Echocardiogr 2000; 1: 180-183.
9. Weesner KM, Bledsoe M, Chauvenet A, et al. Exercise echocardiography in the detection of anthracycline cardiotoxicity. Cancer 1991; 68: 435-438.
10. Smibert E, Carlin JB, Vidmar S, et al. Exercise echocardiography reflects cumulative anthracycline exposure during childhood. Pediatr Blood Cancer 2004; 42: 556-562.
11. Lang D, Hilger F, Binswanger J, et al. Late effects of anthracycline therapy in childhood in relation to the function of the heart at rest and under physical stress. Eur J Pediatr 1995; 154: 340-345.
12. Rowland T, Potts J, Potts T, et al. Cardiovascular responses to exercise in children and adolescents with myocardial dysfunction. Am Heart J 1999; 137: 126-133.
13. Sung RYT, Huang GY, Shing MK, et al. Echocardiography evaluation of cardiac function in paediatric oncology patients with or without anthracycline. Int J Cardiol 1997; 60: 239-248.
14. Landier W, Wallace WHB, Hudson MM. Long-term follow-up of pediatric cancer survivors: Education, surveillance, and screening. Pediatr Blood Cancer 2006; 46: 149-158.
15. Wassermann K, Hansen JE, Sue DY, et al. Principles of exercise testing and interpretation, Chapter 7, 3rd edition. Lippincott Williams and Wilkins.
16. Weisman IM, Zeballos RJ. Cardiopulmonary exercise testing. Pulm Crit Care Update 1995; 11: 2.
17. 2 slope in patients with heart failure: A prognostic comparison. Am Heart J 2004; 147: 354-360.
18. Myers J, Dziekan G, Goebbels U, et al. Influence of high-intensity exercise training on the ventilatory response to exercise in patients with reduced ventricular function. Med Sci Sports Exerc 1999; 31: 929-937.
19. van Dalen EC, van den Brug M, Caron HN, et al. Anthracycline-induced cardiotoxicity: Comparision of recommendations for monitoring cardiac function during therapy in paediatric oncology trials. Eur J Cancer 2006; 42: 3199-3205.
20. Cumming GR, Everatt D, Hastman L. Bruce treadmill test in children: Normal values in a clinic population. Am J Cardiol 1978; 41: 69-75.
21. Arena R, Myers J, Aslam SS, et al. Technical considerations related to the minute ventilation/carbon dioxide output slope in patients with heart failure: A prognostic comparison. Chest 2003; 124: 720-727.
22. Hudson MM, Rai SN, Nunez C, et al. Noninvasive evaluation of late anthracycline cardiactoxicity in childhood cancer survivors. J Clin Oncol 2007; 25: 3635-3643.
23. Elbl L, Hrstkova H, Chaloupka V. The late consequences of anthracycline treatment on left ventricular function after treatment for childhood cancer. Eur J Pediatr 2003; 162: 690-696.
24. Steinherz LJ, Steinherz PG, Tan CT, et al. Cardiac toxicity 4 to 20 years after completing anthracycline therapy. JAMA 1991; 266: 1672-1677.
25. Lipshultz SE, Colan SD, Gelber RD, et al. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood. N Engl J Med 1991; 324: 808-815.
26. Ali MK, Ewer MS, Gibbs HR, et al. Late doxorubicin-associated cardiotoxicity in children. Cancer 1994; 74: 182-188.
27. De Souza AM, Potts EJ, Potts MT, et al. A stress echocardiography study of cardiac function during progressive exercise in pediatric oncology patients treated with anthracyclines. Pediatr Blood Cancer 2007; 49: 56-64.
28. Lipshultz SE, Colan SD. Cardiovascular trials in long-term survivors of childhood cancer. J Clin Oncol 2004; 22: 769-773.
29. Washington RL. Cardiopulmonary sequelae after bone marrow transplantation. J Pediatr 2000; 136: 280-282.
30. Bu'Lock FA, Mott MG, Oakhill A, et al. Left ventricular diastolic filling patterns associated with progressive anthracycline-induced myocardial damage: A prospective study. Pediatr Cardiol 1999; 20: 252-263.
31. Schmitt K, Tulzer G, Merl M, et al. Early detection of doxorubicin and daunorubicin cardiotoxicity by echocardiography: Diastolic versus systolic parameters. Eur J Pediatr 1995; 154: 201-204.
32. Lanzarini L, Bossi G, Laudisa ML, et al. Lack of clinically significant cardiac dysfunction during intermediate dobutamine doses in long-term childhood cancer survivors exposed to anthracyclines. Am Heart J 2000; 140: 315-323.